To have a drug that has an impact on mortality, it’s of huge interest and a benefit for patients with ILD,’ said rheumatologist Voon Ong, MBBS, PhD, who was not involved in the study.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results